Latest Financial Position News

Anatara Lifesciences reports steady progress in its anti-obesity pre-clinical studies with results expected by year-end, while preparing its GaRP gastrointestinal health data for publication amid ongoing commercial talks. The company also announces a key board appointment and a $1.2 million capital raise.

Lumos Diagnostics reported steady quarterly revenue with a 300% surge in product sales, driven by its flagship FebriDx® test. The company inked a landmark US$317 million exclusive U.S. distribution agreement and awaits FDA feedback on its CLIA waiver application.

Forrestania Resources Limited is set to update investors on its rapidly expanding gold resource base and strategic acquisitions in Western Australia during an upcoming webinar. The company’s disciplined approach targets production-ready assets to drive shareholder value.

Fortescue Metals Group kicked off FY26 with record iron ore shipments and strengthened its decarbonisation strategy through new partnerships and a $2 billion Renminbi loan.

Firebrick Pharma reports a $1.94 million cash reserve after a $1.4 million placement, supporting expanded Nasodine sales across Southeast Asia and the US. Board changes and increased operational costs mark a pivotal quarter for the pharmaceutical innovator.

Australian Clinical Labs has announced a 12-month on-market share buy-back program targeting up to 10% of its shares, aiming to enhance shareholder returns without compromising its financial strength.

Vault Minerals delivered a strong September quarter with record gold production and advancing key infrastructure upgrades, setting the stage for significant free cash flow growth in FY27.

Dreadnought Resources reported a cash outflow in Q3 2025 driven by exploration spending but significantly strengthened its balance sheet with an $18 million capital raise post-quarter.

Northern Star Resources reported steady gold production and disciplined costs in Q1 FY26, with the KCGM Mill Expansion project progressing on schedule for early FY27 commissioning. Despite minor operational disruptions, the company maintains its full-year guidance and a robust financial position.

Meeka Metals delivered a strong September quarter with gold production exceeding feasibility study forecasts and costs coming in below plan, underpinning confidence in the Murchison Gold Project’s growth trajectory.

Regis Resources reported a solid September quarter with 90.4koz gold production and a $158 million increase in cash and bullion. Key underground projects at Garden Well Main and Rosemont Stage 3 began ore production, supporting steady FY26 guidance.

Encounter Resources reports significant resource growth at its Aileron Niobium-REE-Copper Project and maiden inferred copper resource at Yeneena, backed by a strong $15 million cash position.